Oocyte-derived R-spondin2 as a Follicle Stimulating Hormone
Oocyte-derived R-spondin2 as a Follicle Stimulating Hormone
批准号:
8368062
负责人:
AARON JW HSUEH
金额:
$23.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-10 至 2014-06-30
关键词:
AdultAdverse effectsAgonistAnimal ModelAnimalsAntralBioinformaticsBiological AssayCell LineCell ProliferationCell membraneClinicalClinical ResearchComplementary DNACoupledCyclic AMPCyclic AMP-Dependent Protein KinasesDNADNA SequenceDataDerivation procedureDevelopmentEmbryonic DevelopmentEpigenetic ProcessFc domainFemale infertilityFertilityFertilizationFollicle Stimulating HormoneFollicle Stimulating Hormone ReceptorFutureGTP-Binding ProteinsGenerationsGenesGonadotropinsGrowthGrowth FactorHair follicle structureHuman Chorionic GonadotropinHuman GenomeImmunoglobulin GIn Situ HybridizationIn VitroInfertilityInjection of therapeutic agentLigandsMammalsMediatingMediationMitochondriaMitochondrial DNAMusMutant Strains MiceNeonatalOocytesOogoniaOrganOvarianOvarian FollicleOvarian Granulosa CellOvarian StimulationsOvaryOvulationPathway interactionsPatientsPhasePhenotypePhysiologyPituitary GonadotropinsPregnancyPremature Ovarian FailurePrimordial FolliclePrincipal InvestigatorProductionProteinsRecombinantsReporterReportingReverse TranscriptionRodent ModelRoleSafetySecondary toSignal PathwaySignal TransductionSomatic CellStagingSubgroupT cell activating factorTCF Transcription FactorTestingTherapeuticTherapeutic AgentsTranscriptional ActivationTreatment ProtocolsWild Type MouseWnt proteinsabstractingadult stem cellbasebeta cateninblastocystclinical applicationflygastrointestinalgranulosa cellhigh rewardhigh riskhybrid proteinin vivomutantnovelnovel strategiesnovel therapeuticsparacrineparalogous genepatient populationprogramspromoterpupreceptorresponse
中文摘要
描述(申请人提供):卵母细胞衍生的R-Spin2作为一种卵泡刺激素摘要:无翼(Wnt)信号通路是从苍蝇到哺乳动物细胞增殖所必需的。尽管多种Wnt配体及其同源Frizzled型受体在卵巢体细胞中表达,但目前尚无研究表明Wnt配体对卵泡生长有促进作用。基于生物信息学和原位杂交分析,我们证明了R-Spin2在初级和高级卵泡的卵母细胞中表达,而在休眠的原始卵泡的卵母细胞中不表达。在人类基因组中有四个R-pondin类似基因(R-pondin1-4),这些分泌的蛋白作为细胞增殖所必需的Wnt信号通路的共同配体,被发现是胃肠道器官和毛囊中的成体干细胞的有效生长因子。最近的研究进一步证明了LGR4/5/6蛋白作为R-响应素配体的同源受体的作用。我们的初步数据表明,在培养的卵巢体细胞中,R-Spin2能够与Wnt配体协同激活Wnt信号通路。在培养的卵巢组织中,R-Spin2处理也促进了卵泡的发育。与FSH不同,R-Spin2不激活cAMP-蛋白激酶A途径,与FSH一起表现出对卵巢细胞增殖的相加刺激作用。我们通过融合R-Spin1和Ig G的Fc结构域,进一步合成了分泌型R-Spin1-Fc激动剂。我们在活体实验中证明了R-Spin1-Fc能够促进新生小鼠初级卵泡生长到次级阶段。用R-Spin1-Fc预处理可诱导出对连续的心电图和hCG有反应的早期有腔卵泡,导致成熟卵母细胞的产生。这些卵母细胞可以在体外受精并发育成囊胚。尽管FSH已被广泛用于女性不孕症的治疗,但一小部分患者表现出低FSH反应,并且没有替代治疗选择。目前的R21方案将首先证明卵巢R-Spindin2配体和LGR4/5/6受体蛋白的表达,以及卵巢LGR4/5/6受体的调节作用。随后将产生重组R-Spin2,以刺激新生野生型小鼠的早期卵泡生长。在使用R-Spin2促进小鼠早期卵泡发育后,将对小鼠进行连续的心电和hCG治疗,以刺激卵泡发育的最后阶段,并获得成熟卵母细胞,用于受精和仔鼠的衍生。然后,我们将使用FSH反应性低的啮齿动物模型(FSH受体单倍体不足杂合子突变体)来测试R-Spin2在促进随后的促性腺激素刺激和成熟卵母细胞生成的早期卵泡发育方面的能力。我们将评估成熟卵母细胞的表观遗传学变化、线粒体完整性和早期胚胎发育,以确保目前治疗方案的有效性和安全性。这之后将衍生出健康的幼崽,作为未来临床应用的基础,使用R-Spin2治疗FSH反应低的不孕症患者。
公共卫生相关性:本申请通过使用野生型和FSH受体单倍体缺陷小鼠展示了卵母细胞来源的R-ponind2促进卵巢早期卵泡发育的能力,为女性不孕不育的治疗提供了一种新的方法。重组R-Spindin2分子的产生和使用可能为低FSH反应不孕症患者的治疗提供一种新的治疗手段。
英文摘要
DESCRIPTION (provided by applicant): Oocyte-derived R-spondin2 as a Follicle Stimulating Hormone Abstract: The Wingless (Wnt) signaling pathway is essential for cell proliferation from flies to mammals. Although multiple Wnt ligands and their cognate Frizzled receptors are expressed in ovarian somatic cells, there is no report demonstrating the ability of Wnt ligands in the promotion of ovarian follicle growth. Based on bioinformatic and in situ hybridization analyses, we demonstrated the exclusive expression of R-spondin2 in oocytes of primary and more advanced follicles but not in oocytes of dormant primordial follicles. There are four R-spondin paralogous genes (R-spondin1-4) in the human genome and these secreted proteins have been found to be potent growth factors for adult stem cells in gastrointestinal organs and hair follicles by serving as co-ligands for the Wnt signaling pathway essential for cell proliferation. Recent studies further demonstrated the role of LGR4/5/6 proteins as the cognate receptors for R-spondin ligands. Our preliminary data demonstrated the ability of R-spondin2 to synergize with Wnt ligands in the activation of the Wnt signaling pathway in cultured ovarian somatic cells. R-spondin2 treatment also promoted ovarian follicle development in cultured ovarian explants. Unlike FSH, R-spondin2 did not activate the cAMP-protein kinase A pathway and showed additive stimulation of ovarian cell proliferation together with FSH. We further generated a secreted R- spondin agonist, R-spondin1-Fc, by fusing R-spondin1 cDNA with that for the Fc domain of IgG. We showed the ability of R-spondin1-Fc to promote the growth of primary follicles to the secondary stage in neonatal mice in vivo. Pre-treatment with R-spondin1-Fc led to the induction of early antral follicles capable of responding to sequential eCG and hCG treatment, leading to the generation of mature oocytes. These oocytes could be fertilized in vitro and developed into blastocysts. Although FSH has been used extensively for the treatment of female infertility, a sub-population of patients showed low FSH responses and has no alternative therapeutic options. The present R21 proposal will first demonstrate the ovarian expression of R-spondin2 ligand and LGR4/5/6 receptor proteins, together with the mediatory role of ovarian LGR4/5/6 receptors. This will be followed by the generation of recombinant R-spondin2 to stimulate early follicle growth in neonatal wild type mice. Following the promotion of early ovarian follicle development using R-spondin2, mice will be treated sequentially with eCG and hCG to stimulate the final phase of follicle development and to derive mature oocytes for fertilization and the derivation of pups. We will then use a rodent model of low FSH responsiveness (FSH receptor haploinsufficient heterozygous mutants) to test the ability of R-spondin2 in the promotion of early follicle development for subsequent gonadotropin stimulation and the generation of mature oocytes. We will evaluate epigenetic changes, mitochondrial integrity and early embryonic development of mature oocytes to insure the efficacy and safety of the present treatment regimen. This will be followed by the derivation of healthy pups as the basis for future clinical application using R-spondin2 to treat infertile patients with low FSH responses.
PUBLIC HEALTH RELEVANCE: The present application represents a new approach for female infertility treatment by demonstrating the ability of oocyte-derived R-sponind2 to promote early ovarian follicle development using wild type and FSH receptor haploinsufficient mice. The generation and use of recombinant R-spondin2 molecules could provide a new therapeutic agent for the treatment of infertile patients with low FSH responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Oocyte-derived R-spondin2 as a Follicle Stimulating Hormone
-
批准号:8526219
-
项目类别:
-
资助金额:$18.92万
-
财政年份:2012
-
负责人:AARON JW HSUEH
-
依托单位:
Derivation of Mature Oocytes from Human Primordial Follicles
-
批准号:7964577
-
项目类别:
-
资助金额:$23.77万
-
财政年份:2010
-
负责人:AARON JW HSUEH
-
依托单位:
Oocyte factors for reprogramming to pluripotency
-
批准号:7815481
-
项目类别:
-
资助金额:$99.94万
-
财政年份:2010
-
负责人:AARON JW HSUEH
-
依托单位:
Activation of dormant ovarian follicles
-
批准号:7640438
-
项目类别:
-
资助金额:$24.03万
-
财政年份:2009
-
负责人:AARON JW HSUEH
-
依托单位:
Activation of dormant ovarian follicles
-
批准号:7849497
-
项目类别:
-
资助金额:$20.04万
-
财政年份:2009
-
负责人:AARON JW HSUEH
-
依托单位:
Identification of ligand signaling for the stem cell marker LGR5
-
批准号:7632206
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2008
-
负责人:AARON JW HSUEH
-
依托单位:
Identification of ligand signaling for the stem cell marker LGR5
-
批准号:7510574
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2008
-
负责人:AARON JW HSUEH
-
依托单位:
Physiology of LGR7 and LGR8 in Gonadal Tissues
-
批准号:6873661
-
项目类别:
-
资助金额:$28.81万
-
财政年份:2003
-
负责人:AARON JW HSUEH
-
依托单位:
Physiology of LGR7 and LGR8 in Gonadal Tissues
-
批准号:6745135
-
项目类别:
-
资助金额:$28.81万
-
财政年份:2003
-
负责人:AARON JW HSUEH
-
依托单位:
Physiology of LGR7 and LGR8 in Gonadal Tissues
-
批准号:7055339
-
项目类别:
-
资助金额:$28.14万
-
财政年份:2003
-
负责人:AARON JW HSUEH
-
依托单位:
Physiology of LGR7 and LGR8 in Gonadal Tissues
-
批准号:7224802
-
项目类别:
-
资助金额:$27.32万
-
财政年份:2003
-
负责人:AARON JW HSUEH
-
依托单位:
Physiology of LGR7 and LGR8 in Gonadal Tissues
-
批准号:6605276
-
项目类别:
-
资助金额:$28.45万
-
财政年份:2003
-
负责人:AARON JW HSUEH
-
依托单位:
G Protein-Coupled Receptors with Leucine-Rich Repeats
-
批准号:6400133
-
项目类别:
-
资助金额:$15.71万
-
财政年份:2001
-
负责人:AARON JW HSUEH
-
依托单位:
G Protein-Coupled Receptors with Leucine-Rich Repeats
-
批准号:6517827
-
项目类别:
-
资助金额:$15.71万
-
财政年份:2001
-
负责人:AARON JW HSUEH
-
依托单位:
BIOACTIVE FSH AND REPRODUCTION
-
批准号:2471427
-
项目类别:
-
资助金额:$20.84万
-
财政年份:1997
-
负责人:AARON JW HSUEH
-
依托单位:
BIOACTIVE FSH AND REPRODUCTION
-
批准号:6682944
-
项目类别:
-
资助金额:$25.8万
-
财政年份:1997
-
负责人:AARON JW HSUEH
-
依托单位:
STRUCTURE/FUNCTIONAL ANALYSIS OF INHIBIN
-
批准号:2026393
-
项目类别:
-
资助金额:$8.05万
-
财政年份:1997
-
负责人:AARON JW HSUEH
-
依托单位:
BIOACTIVE FSH AND REPRODUCTION
-
批准号:2888950
-
项目类别:
-
资助金额:$21.83万
-
财政年份:1997
-
负责人:AARON JW HSUEH
-
依托单位:
BIOACTIVE FSH AND REPRODUCTION
-
批准号:6387532
-
项目类别:
-
资助金额:$22.88万
-
财政年份:1997
-
负责人:AARON JW HSUEH
-
依托单位:
BIOACTIVE FSH AND REPRODUCTION
-
批准号:6406960
-
项目类别:
-
资助金额:$27.62万
-
财政年份:1997
-
负责人:AARON JW HSUEH
-
依托单位:
海外基金